Thyrocare Technologies Limited announced the appointment of legendary actor Madhuri Dixit as its brand ambassador on January 27, 2026, coinciding with India's 77th Republic Day celebrations. The strategic partnership represents the diagnostic company's strengthened commitment to promoting preventive healthcare awareness across the country.

Strategic Partnership Details

The collaboration between Thyrocare and Madhuri Dixit focuses on three key areas:

Madhuri Dixit was selected beyond celebrity value for the trust and credibility she has earned over decades. Her discipline, consistency, and commitment to well-being mirror Thyrocare's philosophy that long-term health is built through small, regular actions, starting with knowing health parameters.

Leadership Statements

Rahul Guha, Managing Director & CEO, Thyrocare and API Holdings, commented on the appointment: "At Thyrocare, we exist to remove barriers such as price, access and inconvenience that keep people away from timely diagnostics. Preventive healthcare is the single biggest lever to improve health outcomes in India. Madhuri Dixit brings unmatched trust and credibility, and together, we want to make routine health check-ups a non-negotiable part of Indian life."

Madhuri Dixit expressed her enthusiasm about the partnership: "I strongly believe that taking charge of one's health early makes all the difference. Thyrocare has built its reputation on quality, affordability, and putting patients first. I'm proud to partner with a brand that is focused on empowering people to prioritise regular health check-ups."

Company Profile and Market Position

Thyrocare Technologies Limited operates as India's first fully automated laboratory chain with a strong presence across the country. The company has established itself as a leading diagnostics disruptor by delivering high-quality diagnostics at scale with affordable pricing.

Quality Accreditations

Thyrocare holds several internationally renowned quality certifications:

• ISO 9001-2000 rating obtained in 2001, upgraded to ISO 9001:2015
• National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation in 2005
• College of American Pathologists (CAP) accreditation in 2005

Strategic Vision

The appointment reinforces Thyrocare's long-term commitment to building a prevention-first healthcare ecosystem. The company aims to shift India's healthcare approach from reactive treatment to proactive health management, making informed decisions, early detection, and accessible diagnostics the foundation for better health outcomes for millions of Indians.

This partnership represents Thyrocare's continued efforts to expand access to quality diagnostic services while maintaining affordability, ensuring that routine health monitoring becomes an integral part of Indian households' healthcare practices.

Thyrocare Technologies Limited has been honored with two prestigious awards at the 4th Edition of National Diagnostics Forum & Awards 2026. The recognition ceremony, organized by Voice of Healthcare (VOH), took place on January 21, 2026, at Courtyard by Marriott, Mumbai.

Awards Recognition

The company received recognition in two key categories that highlight its market leadership and service excellence:

Company's Mission and Values

The awards reflect Thyrocare Technologies Limited's core mission to ensure universal access to quality and affordable diagnostic services. The company has built its reputation on several key pillars that contributed to this recognition:

• Strong focus on patient-centric care
• Commitment to innovation in diagnostic services
• Operational excellence across its network
• Accessibility and affordability of diagnostic solutions

Regulatory Compliance

The company disclosed this achievement in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information has been made available on the company's investor website at investor.thyrocare.com/announcements/ for stakeholder access.

Event Details

The National Diagnostics Forum & Awards 2026 represents a significant industry platform that recognizes excellence in the healthcare diagnostics sector. The 4th edition of this event brought together industry leaders and stakeholders to celebrate achievements in diagnostic services and innovation.

This recognition underscores Thyrocare Technologies Limited's position as a leading diagnostic services provider in India, emphasizing its commitment to quality healthcare delivery and patient satisfaction.